Lung - Cancer

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

September 10, 2026 | Joel DunningGold ContributorSilver Commentor

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the UAE. They discussed the advantages...

JANS Article

Right Basilar Segmental Autologous Lung Transplantation With Carinal Reconstruction for Central Lung SCC

September 24, 2026 | Akshay PatelSilver Contributor

This case report describes a 75-year-old patient with a centrally located squamous cell carcinoma extending from the carina to the right intermediate bronchus and the superior segment of the lower...

JANS Article

An STS General Thoracic Surgery Database Analysis of the Association Between LN Dissection and Chylothorax

September 24, 2026 | Akshay PatelSilver Contributor

This Society of Thoracic Surgeons General Thoracic Surgery Database analysis found that postoperative chylothorax risk increases with the extent of lymph-node dissection during pulmonary resection. Although uncommon, chylothorax was associated...

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

September 10, 2026 | Joel DunningGold ContributorSilver Commentor

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...

JANS Article

Tumor Mutational Burden as a Predictor of Immune-Related Adverse Events in Patients With Advanced Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: A Brief Report

September 3, 2026 | Akshay PatelSilver Contributor

High tumor mutational burden (TMB) predicts not only response to immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) but also immune-related toxicity. In this single-center cohort of...

JANS Article

Lung Cancer Screening and USPSTF Recommendations

March 6, 2025 | Erica CurcioGold Contributor

Lung cancer remains the leading cause of cancer-related deaths, and low-dose computed tomography screening can reduce mortality for high-risk individuals. In 2021, the US Preventive Services Task Force (USPSTF) expanded...

JANS Article

Intracavitary Cisplatin-Fibrin Followed by Irradiation Improved Tumor Control Compared to the Single Treatments in a Mesothelioma Rat Model

January 30, 2025 | Akshay PatelSilver Contributor

This murine model study investigated a novel combination treatment for pleural mesothelioma using intracavitary cisplatin-fibrin gel (cis-fib) and adjuvant irradiation (IR). Conducted on an orthotopic immunocompetent rat model, the study...

JANS Article

Lung Transplant Outcome From Selected Older Donors (≥70 Years) Equals Younger Donors (

January 2, 2025 | Akshay PatelSilver Contributor

This study evaluates the outcomes of bilateral lung transplantation (LTx) using grafts from donors aged 70 years or older, compared with those from younger donors. Conducted at a single center...

JANS Article

Prevalence of Invasive Lung Cancer in Pure Ground Glass Nodules Less Than 30 mm: A Systematic Review

December 19, 2024 | Akshay PatelSilver Contributor

This article examines the malignancy potential of pure ground-glass nodules (pGGNs) under 30 mm, challenging the notion that these nodules carry minimal invasive cancer risk. After analyzing 28 observational studies...

JANS Article

The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-small Cell Lung Cancer

December 5, 2024 | Akshay PatelSilver Contributor

This article provides a consensus-based approach for determining the resectability and optimal management strategies for locally advanced non-small cell lung cancer (NSCLC). The expert panel recommends evaluating resectability through multidisciplinary...

JANS Article

European Multicentre Study Evaluating the Prognosis of Peripheral Early-Stage Lung Adenocarcinoma Patients Operated on by Segmentectomy or Lobectomy

December 5, 2024 | Akshay PatelSilver Contributor

This article assesses the outcomes of segmentectomy versus lobectomy in treating peripheral, early-stage lung adenocarcinoma. In a multicenter study involving 674 patients, the authors compared overall survival (OS), lung cancer-specific...

JANS Article

Better Survival With Lobectomy Versus Sublobar Resection in Patients With Hypermetabolic C-Stage IA Lung Cancer on Positron Emission Tomography/Computed Tomography 

November 7, 2024 | Mujtaba MubashirGold Contributor

Recently, the CALGB 140503 trial and the JCOG0802/WJOG4607L showed the non-inferiority of sublobar resections compared to lobectomy for 3). Both the five-year overall and disease-free survival rates were worse after...

JANS Article

Clinical and Financial Outcomes of Pulmonary Resection for Lung Cancer in Safety-Net Hospitals

November 7, 2024 | Akshay PatelSilver Contributor

This article explores the disparities in access to minimally invasive surgery (MIS) for stage I non-small cell lung cancer (NSCLC) based on socioeconomic status. After analyzing data from the National...

LOAD MORE
ADVERTISE ON CTSNET